drug
tegavivint
Phase 2updated 6mo agoby Iterion Therapeutics Inc
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying tegavivint
- phase2Study of Tegavivint Plus Zanzalintinib in Patients With Advanced Hepatocellular Carcinoma
- phase2Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
- phase1Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
- phase2A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma
News(1)
- Once undruggable, the Wnt/B-catenin pathway shows increasing promiseEarly-stage clinical data from our company and others point to the Wnt/β-catenin pathway as a new avenue for targeting multiple cancer types.biospace · 18d ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that